Literature DB >> 11409717

Test-retest reliability of DSC MRI CBV mapping in healthy volunteers.

M E Henry1, M J Kaufman, N Lange, M E Schmidt, S Purcell, J Cote, D M Perron-Henry, E Stoddard, B M Cohen, P F Renshaw.   

Abstract

Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI) can be used to generate high resolution maps of cerebral blood volume (CBV). To determine the test-retest reliability, CBV was measured in eight volunteers on two occasions, separated by 4 weeks. The mean ratio (scan 2/scan 1) for 72 cortical regions of interest (ROIs) was 1.03, with a coefficient of variation of 14%. The correlation between the first and second scans was 0.73 (p < 0.0001; 95%). In five hand-drawn ROIs, the mean ratio was 1.08, with a coefficient of variation of 12%. The correlation between scans was 0.84 (p < 0.0001). The data presented here support the hypothesis that DSC MRI CBV mapping has acceptable test-retest reliability.

Entities:  

Mesh:

Year:  2001        PMID: 11409717     DOI: 10.1097/00001756-200106130-00011

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Investigation of long-term reproducibility of intrinsic connectivity network mapping: a resting-state fMRI study.

Authors:  Y-h Chou; L P Panych; C C Dickey; J R Petrella; N-k Chen
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

2.  Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI.

Authors:  David S Smith; Xia Li; James V Gambrell; Lori R Arlinghaus; C Chad Quarles; Thomas E Yankeelov; E Brian Welch
Journal:  IEEE Trans Med Imaging       Date:  2011-10-14       Impact factor: 10.048

3.  Emerging techniques and technologies in brain tumor imaging.

Authors:  Benjamin M Ellingson; Martin Bendszus; A Gregory Sorensen; Whitney B Pope
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

4.  Inflow-vascular space occupancy (iVASO) reproducibility in the hippocampus and cortex at different blood water nulling times.

Authors:  Swati Rane; Pratik Talati; Manus J Donahue; Stephan Heckers
Journal:  Magn Reson Med       Date:  2015-07-20       Impact factor: 4.668

5.  Improved Spatiotemporal Resolution of Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors Using Simultaneous Multi-Slice Echo-Planar Imaging.

Authors:  A Chakhoyan; K Leu; W B Pope; T F Cloughesy; B M Ellingson
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-26       Impact factor: 3.825

6.  Regional cerebral blood flow and blood volume in patients with subcortical arteriosclerotic encephalopathy (SAE).

Authors:  Friedemann J Gückel; Gunnar Brix; Michael Hennerici; Robert Lucht; Christine Ueltzhöffer; Wolfgang Neff
Journal:  Eur Radiol       Date:  2007-03-06       Impact factor: 7.034

7.  Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin Labeling.

Authors:  George W J Harston; Thomas W Okell; Fintan Sheerin; Ursula Schulz; Phil Mathieson; Ian Reckless; Kunal Shah; Gary A Ford; Michael A Chappell; Peter Jezzard; James Kennedy
Journal:  Stroke       Date:  2016-11-22       Impact factor: 7.914

8.  Clinical Validation of Automatable Gaussian Normalized CBV in Brain Tumor Analysis: Superior Reproducibility and Slightly Better Association with Survival than Current Standard Manual Normal Appearing White Matter Normalization.

Authors:  Lei Qin; Xiang Li; Angie Li; Suchun Cheng; Jinrong Qu; Katherine Reinshagen; Jiani Hu; Nathan Himes; Gao Lu; Xiaoyin Xu; Geoffrey S Young
Journal:  Transl Oncol       Date:  2018-09-11       Impact factor: 4.243

9.  Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients.

Authors:  Kourosh Jafari-Khouzani; Kyrre E Emblem; Jayashree Kalpathy-Cramer; Atle Bjørnerud; Mark G Vangel; Elizabeth R Gerstner; Kathleen M Schmainda; Kamran Paynabar; Ona Wu; Patrick Y Wen; Tracy Batchelor; Bruce Rosen; Steven M Stufflebeam
Journal:  Transl Oncol       Date:  2015-06       Impact factor: 4.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.